Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B7QK | ISIN: GB0034330679 | Ticker-Symbol: DWV
Frankfurt
19.04.24
09:15 Uhr
0,115 Euro
-0,035
-23,33 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
ANGLE PLC Chart 1 Jahr
5-Tage-Chart
ANGLE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1330,14619:35

Aktuelle News zur ANGLE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.04.Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024312PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCECTC HER2 assay being developed for HER2 targeted drugs and antibody drug conjugates presented at internationally renowned...
► Artikel lesen
22.03.Angle PLC Announces Parsortix at European Breast Cancer Conference258PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCEANGLE presenting two posters highlighting the utility of the Company's new Portrait+ CTC Staining Kit and Portrait...
► Artikel lesen
22.01.IN BRIEF: Angle highlights supportive data for DNA analysis tool1
22.01.Angle PLC Announces Potential Utility in Precision Oncology275REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGYPaper published in the journal "Current Issues in Molecular Biology" special issue: advanced...
► Artikel lesen
10.01.Angle PLC Announces Standard Form for Notification of Major Holdings297GUILDFORD, SURREY / ACCESSWIRE / January 10, 2024 / ANGLE plc:TR-1: Standard form for notification of major holdings:NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA...
► Artikel lesen
04.01.Angle shares soar following "breakthrough" cancer diagnostics results2
04.01.AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up2
04.01.Angle receives 'breakthrough results' from DNA molecular analysis3
04.01.Angle PLC Announces Breakthrough Clinical Results235BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCERCombined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample highlights potential...
► Artikel lesen
02.01.Angle locks in $250,000 contract with Eisai4
02.01.IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial3
02.01.ANGLE Plc Signs Contract With Eisai3
02.01.Angle PLC - Contract announcement with Eisai Inc.490Pilot study for ANGLE's Portrait HER2 assay in Phase II study of HER2 targeting antibody-drug conjugate, BB-1701GUILDFORD, SURREY / ACCESSWIRE / January 2, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a...
► Artikel lesen
11.12.23Angle PLC Announces Broker Announcement239GUILDFORD, SURREY / ACCESSWIRE / December 11, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use...
► Artikel lesen
11.12.23Angle PLC Announces Parsortix Unlocks Opportunities for Drug Discovery238USE OF PARSORTIX SYSTEM IN PRE-CLINICAL MODEL UNLOCKS OPPORTUNITIES FOR DRUG DISCOVERYHarvested CTCs reveal gene expression profile associated with development and progression of brain metastasis in...
► Artikel lesen
05.12.23IN BRIEF: Angle launches diagnostic kit at cancer symposium2
05.12.23ANGLE plc: ANGLE launches Portrait+ CTC kit at SABCS312ANGLE LAUNCHES PORTRAIT+ CTC KIT AT SAN ANTONIO BREAST CANCER SYMPOSIUMANGLE's Portrait+ CTC staining kit combines the power of Parsortix® technology with an optimised immunofluorescent assayThe test...
► Artikel lesen
09.11.23Angle says build up of revenue slower than hoped; launches test3
09.11.23Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies157ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIESANGLE's Portrait PD-L1 test uses CTCs harvested from the Parsortix system to investigate real-time patient PD-L1 status for clinical studiesThe...
► Artikel lesen
09.11.23Angle PLC Announces Trading and Business Update186Revenue recognised for 2023 expected to be up 120% at c. £2.2 million with sales secured in 2023 expected to be c. £3.3 millionRevenue recognised for 2024 expected to treble compared to 2023Cash runway...
► Artikel lesen
Seite:  Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1